Standard for collecting and reporting outcomes of IOL–based refractive surgery: update for enhanced monofocal, EDOF, and multifocal IOLs

Fernández, Joaquín; Ribeiro, Filomena; Rodríguez‐Vallejo, Manuel; Dupps, William J.; Werner, Liliana; Srinivasan, Sathish; Kohnen, Thomas

doi:10.1097/j.jcrs.0000000000001013

Cited by 24 publications

(25 citation statements)

References 38 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The CONSORT statement, the recommendations, and standards for writing IOL manuscripts were used as guidance for this article. [17][18][19] Inclusion and Exclusion Criteria Inclusion criteria were patients aged between 45 years and 85 years who could complete the planned follow-up program after undergoing bilateral surgery, with corneal astigmatism less than 1.50 diopter (D), axial length between 21 mm and 27 mm, and mean keratometry between 40 diopter (D) and 46 D. Patients with previous ocular surgery or visual comorbidity, pupil abnormality, surgical complications, or impaired capacity for consent were excluded from recruitment.…”

Section: Methodsmentioning

confidence: 99%

Enhanced Versus Conventional Monofocal Intraocular Lens Clinical Results in Cataract Patients: A Randomized Clinical Trial

Donoso,

Torres,

Klagges

et al. 2023

J Cataract Refract Surg

View full text Add to dashboard Cite

Purpose: To compare clinical outcomes between an enhanced and a conventional monofocal intraocular lens (IOL) after cataract surgery. Setting: Ophthalmology Unit, Hospital del Salvador, University of Chile (tertiary care hospital). Design: Double-masked, prospective randomized controlled trial. Methods: 66 healthy adults with corneal astigmatism less than 1.50 diopters and axial length between 21 and 27 mm were randomly allocated (1:1) for bilateral phacoemulsification with either an enhanced monofocal IOL (ICB00) or a conventional aspheric monofocal IOL (ZCB00) implant. The refractive target was emmetropia in both eyes. Visual acuities, defocus curves, Catquest-9SF, and quality of vision (QoV) were measured 3 months postoperatively. Results: Binocular uncorrected intermediate visual acuity was improved in patients implanted with the enhanced monofocal lens (0.37 ± 0.12) compared with the conventional monofocal (0.45 ± 0.10) (P < .01). There were no significant differences in corrected distance visual acuity (CDVA), Catquest-9SF, or QoV scores. Conclusions: The enhanced monofocal IOL provided 1 additional line of intermediate visual acuity after cataract surgery. There was no significant change in either CDVA or QoV.

show abstract

Section: Methodsmentioning

confidence: 99%

Enhanced Versus Conventional Monofocal Intraocular Lens Clinical Results in Cataract Patients: A Randomized Clinical Trial

Donoso,

Torres,

Klagges

et al. 2023

J Cataract Refract Surg

View full text Add to dashboard Cite

show abstract

“…Visual acuities and refractive results were presented in the standard plots for primary outcomes in studies with presbyopia-correcting IOLs [ 10 ]. Mean MRSE was adjusted for infinity by adding − 0.20 D for 5 m examination.…”

Section: Methodsmentioning

confidence: 99%

Clinical Performance of a Hydrophobic Acrylic Diffractive Trifocal Intraocular Lens in a Japanese Population

Mori

Suzuki

Noguchi³

et al. 2022

Ophthalmol Ther

View full text Add to dashboard Cite

Introduction: In this study, clinical performance of a hydrophobic acrylic diffractive trifocal intraocular lens (IOL) with double C-loop haptics was evaluated in Japanese cataract eyes. Methods: Twenty-three patients had bilateral cataract surgery with the implantation of a trifocal IOL with double C-loop haptics. Postoperative examinations at 6 months included assessing uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA) at 5 m, uncorrected intermediate visual acuity (UIVA), distance-corrected intermediate visual acuity (DCIVA) at 80 cm, uncorrected near visual acuity (UNVA) and distance-corrected near visual acuity (DCNVA) at 40 cm. Binocular defocus, contrast sensitivity, spectacle independence, symptoms of photic phenomena and quality of vision (QOV) were also observed. Results: Twenty-three patients received 46 IOLs binocularly. Manifest refraction spherical equivalent was -0.227 ± 0.385 D (mean ± standard deviation) at 6 months postoperatively. Binocular UDVA, binocular UIVA and binocular UNVA were -0.101 ± 0.065, -0.021 ± 0.079 and 0.022 ± 0.095 logMAR units, respectively. Binocular CDVA, binocular DCIVA and binocular DCNVA were -0.151 ± 0.044, -0.042 ± 0.067 and -0.011 ± 0.080 logMAR, respectively. Binocular CDVA of 0.00 logMAR or better was obtained in the defocus from -3.0 D until ? 0.5 D. Only 8.7% of patients required the use of spectacles postoperatively. There were no symptoms of glare, halo and light disturbance in 78.3%, 56.5% and 69.6% of patients, respectively. QOV scores significantly improved postoperatively (P \ 0.0001). Conclusion:The hydrophobic acrylic trifocal IOL with double C-loop haptics provides good visual performance at all distances and produces high spectacle independence rate and patient satisfaction. Trial Registration Number: NCT04699266 (Clinicaltrials.gov).

show abstract

“…Patient-reported outcomes (PROs) were obtained in the preoperative stage and at 6 months by means of using the following questionnaires: the Convergence Insufficiency Symptoms Survey (CISS) to assess the near vision symptoms [ 16 ]; the Patient-Reported Spectacle Independence Questionnaire (PRSIQ) for the assessment of spectacle dependence [ 17 ]; the Vision and Night Driving Questionnaire (VND-Q) for assessing the difficulties driving at night [ 18 ]; and single questions to evaluate the dysphotopsia, and satisfaction with the procedure and desire to be submitted to the same procedure if patient had to take the decision again [ 19 ]. Adverse events were recorded during all the follow-up visits.…”

Section: Methodsmentioning

confidence: 99%

Effectiveness of SMILE Combined with Micro-Monovision in Presbyopic Patients: A Pilot Study

Fernández¹,

Alonso-Aliste

Burguera³

et al. 2023

Life

Self Cite

View full text Add to dashboard Cite

Binocular summation along all defocus range after a micro-monovision procedure has scarcely been studied. The aim of this pilot study was to evaluate the efficacy of SMILE combined with different levels of micro-monovision in presbyopic patients and to assess the binocular summation effect on contrast sensitivity defocus curves (CSDC) at the 6-month follow-up. Efficacy was assessed on the basis of visual acuity (VA) and stereopsis at far, intermediate, and near distances. Patient-reported outcomes (PROs) and binocular CSDC were also evaluated. Six patients completed the study with a programmed median anisometropia of 0.81 Diopter. The median binocular uncorrected VA was better than 0 logMAR at the three evaluated distances, and stereopsis was not impaired in any patient, achieving a median of ≤119 arcsec at any distance. CSDC increased binocularly after surgery, significantly in the range of −2 to −3 D (p < 0.05). No clinically relevant changes were observed in PROs compared with the preoperative period, and all patients achieved spectacle independence at intermediate/near distance and were likely or very likely to undergo the same surgery. In conclusion, micro-monovision with SMILE could be an effective procedure, with results that might be comparable to other laser correction techniques specifically designed for presbyopia correction.

show abstract

Standard for collecting and reporting outcomes of IOL–based refractive surgery: update for enhanced monofocal, EDOF, and multifocal IOLs

Cited by 24 publications

References 38 publications

Enhanced Versus Conventional Monofocal Intraocular Lens Clinical Results in Cataract Patients: A Randomized Clinical Trial

Enhanced Versus Conventional Monofocal Intraocular Lens Clinical Results in Cataract Patients: A Randomized Clinical Trial

Clinical Performance of a Hydrophobic Acrylic Diffractive Trifocal Intraocular Lens in a Japanese Population

Effectiveness of SMILE Combined with Micro-Monovision in Presbyopic Patients: A Pilot Study

Contact Info

Product

Resources

About